INNOCOLL ANNOUNCES NEW DISTRIBUTION AGREEMENTS FOR COLLARX GENTAMICIN SURGICAL IMPLANT

Innocoll, Inc. announced its sales and marketing subsidiary, Innocoll Pharmaceuticals Ltd., has recently signed distribution agreements for its CollaRx GENTAMICIN SURGICAL IMPLANT in five additional territories; Turkey, Greece, Romania, Bulgaria, and Nigeria. The product is indicated for the treatment and prevention of post-operative acquired infection and was acquired by Innocoll from Schering Plough in July of this year. Innocoll has since assumed all sales, marketing and distribution activities for the product.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-12-2005/0004231774&EDATE=)